Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: April 2012

Chapter 11 - Anticoagulants and procoagulants

from Section 2 - Cardiac pharmacology

Further reading

GillR, HerbertsonM, VuylstekeA, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120(1): 21–7.
KosterA, SchirmerU.Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Curr Opin Anaesthesiol 2011; 24(1): 92–7.
MerryAF.Focus on thrombin: alternative anticoagulants. Semin Cardiothorac Vasc Anesth 2007; 11(4): 256–60.
MurkinJM, FalterF, GrantonJ, YoungB, BurtC, ChuM.High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110(2): 350–3.
MurphyGS, MarymontJH.Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2007; 21(1): 113–26.
PifarréR (Ed). New Anticoagulants for the Cardiovascular Patient. Philadelphia: Hanley & Belfus, 1997.